XtalPi Holdings Limited (HKG:2228)
Hong Kong · Delayed Price · Currency is HKD 7.71
-0.34 (-4.16%)
Aug 21, 2026, 4:08 PM HKT
XtalPi Holdings Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 679.17 | 802.62 | 266.43 | 174.42 | 133.35 | 62.8 |
Revenue Growth | -15.38% | 201.25% | 52.75% | 30.80% | 112.35% | - |
Gross Profit Gross Profit Growth | 349.85 | 559.18 | 123.43 | 48.24 | 73.25 | 35.38 |
Operating Income Operating Income Growth | -846.2 | -461.98 | -714.76 | -761.5 | -542.97 | -327.84 |
Net Income Net Income Growth | -210.95 | 123.75 | -1,517 | -1,914 | -1,439 | -2,137 |
Earnings Per Share EPS Growth | -0.05 | 0.03 | -0.79 | -3.96 | -2.97 | -4.43 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Drug Discovery Solutions Drug Discovery Solutions Growth | 302.83 | 537.93 | 103.66 | 87.73 | 87.67 | 39.35 |
AI for Science intelligent solutions AI for Science intelligent solutions Growth | 376.34 | 264.69 | 162.77 | 86.69 | 45.69 | 23.45 |
Total Total Growth | 679.17 | 802.62 | 266.43 | 174.42 | 133.35 | 62.8 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,666 | 7,062 | 3,112 | 2,838 | 3,483 | 3,838 |
Total Debt Total Debt Growth | 3,118 | 441.86 | 148.77 | 11,036 | 9,450 | 7,834 |
Net Cash (Debt) Net Cash Growth | 5,548 | 6,620 | 2,963 | -8,199 | -5,968 | -3,996 |
Net Cash Growth | -16.20% | 123.42% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.38 | 1.66 | 1.54 | -16.94 | -12.33 | -8.29 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -326.17 | -165.41 | -478.68 | -567.56 | -429.1 | -253.75 |
Capital Expenditures CapEx Growth | -85.75 | -71.41 | -58.11 | -123.79 | -193.42 | -160.58 |
Free Cash Flow Free Cash Flow Growth | -411.92 | -236.82 | -536.79 | -691.36 | -622.52 | -414.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.51% | 69.67% | 46.33% | 27.66% | 54.93% | 56.34% |
Operating Margin | -124.59% | -57.56% | -268.27% | -436.59% | -407.17% | -522.05% |
Pretax Margin | -24.23% | 16.86% | -568.57% | -1092.95% | -1078.80% | -3403.45% |
Profit Margin | -31.06% | 15.42% | -569.23% | -1097.57% | -1078.72% | -3403.38% |
FCF Margin | -60.65% | -29.51% | -201.47% | -396.37% | -466.82% | -659.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 295.63 | - | - | - | - |
PS Ratio | 42.32 | 45.58 | 72.00 | - | - | - |